AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest

AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest

Wei Zhou,1– 3 Weiyang Lou,4 Junru Chen,1– 3 Bisha Ding,4 Binjie Chen,2,3,5 Haiyang Xie,1– 3 Lin Zhou,1– 3 Shusen Zheng,1– 3 Donghai Jiang2,3,5 1Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School...

Full description

Bibliographic Details
Main Authors: Zhou W, Lou W, Chen J, Ding B, Chen B, Xie H, Zhou L, Zheng S, Jiang D
Format: Article
Language:English
Published: Dove Medical Press 2021-02-01
Series:OncoTargets and Therapy
Subjects:
hepatocellular carcinoma
sorafenib resistance
ag-1024
mtor
g1/s arrest
Online Access:https://www.dovepress.com/ag-1024-sensitizes-sorafenib-resistant-hepatocellular-carcinoma-cells--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/ag-1024-sensitizes-sorafenib-resistant-hepatocellular-carcinoma-cells--peer-reviewed-article-OTT

Similar Items